Form 4: Zimmer Biomet Executive Stellato Reports Stock Transactions

Paul A. Stellato, VP, Controller & CAO of Zimmer Biomet Holdings, Inc., reports the vesting of restricted stock units and related transactions.

Summary

• Paul A. Stellato, a VP, Controller & CAO at Zimmer Biomet Holdings, Inc., filed a Form 4 on February 24, 2025.
• The report details transactions related to common stock and restricted stock units (RSUs).
• On February 20, 2025, 702 RSUs vested, resulting in the acquisition of 702 shares of common stock.
• Simultaneously, 258 shares were withheld to cover tax obligations at a price of $103.46 per share.
• Stellato also acquired 100 shares under the Employee Stock Purchase Plan through February 18, 2025.
• Following these transactions, Stellato directly owns 1,926 shares of common stock and 1,402 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions, with neutral sentiment.

Positives

• The vesting of RSUs indicates a form of compensation and alignment of the executive's interests with the company's performance.

Future Outlook

The remaining RSUs will vest in two installments on February 20, 2026, and February 20, 2027.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which are closely monitored by investors.

Stakeholder Impact

• Shareholders can monitor insider transactions for insights into management's perspective on the company's value.

Key Dates